ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 431,04
-0,79%
Dow Jones
41 938,45
-1,63%
DAX
20 214,79
-0,51%
Brent Oil
79,285
3,07%
Bitcoin
94 641,09
2,41%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Avid Bioservices Inc (CDMO) Cours

Avid Bioservices Inc

Avid Bioservices Inc (CDMO)

NASDAQ
12,41
0,03
(0,24%)
À la fermeture: 10 Janvier 10:00PM
Retardé de 15 minutes
12,41
0,01
( 0,08% )
Après les heures de négociation: 10:09PM
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
12,41
Prix Achat
12,37
Prix Vente
12,43
Volume échangé
1 037 326
12,38 Fourchette du Jour 12,42
5,90 Plage de 52 semaines 12,48
Cap du marché
793,785M
Clôture Veille
12,38
Ouverture
12,39
Dernière Transaction
12
@
12.41
Dernière heure de transaction
22:20:00
Volume financier
US$ 12 855 516
VWAP
12,3929
Volume moyen (3 m)
2 031 678
Actions en circulation
63 963 302
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-5,63
Bénéfice par action (BPA)
-2,2
Chiffre d'affairess
139,91M
Bénéfice net
-140,75M

À propos de Avid Bioservices Inc

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP cli... Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.peregrineinc.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Avid Bioservices Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker CDMO. Le dernier cours de clôture d'Avid Bioservices était de US$12,38. Au cours de la dernière année, les actions de Avid Bioservices ont été négociées dans une fourchette de prix de US$ 5,90 à US$ 12,48.

Avid Bioservices compte actuellement 63 963 302 actions en circulation. La capitalisation boursière d'Avid Bioservices est de US$791,87 million. Avid Bioservices a un ratio cours/bénéfice (ratio PE) de -5.63.

CDMO Dernières nouvelles

Plus de nouvelles

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

08 Janvier 2025
Edgar (US Regulatory)

Avid Bioservices Files Investor Presentation Highlighting Value Maximizing Transaction with GHO and Ampersand

TUSTIN, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization...

08 Janvier 2025
GlobeNewswire Inc.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

08 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

03 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

03 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

03 Janvier 2025
Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

30 Décembre 2024
Edgar (US Regulatory)

Avid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by GHO and Ampersand

TUSTIN, Calif., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization...

30 Décembre 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

28 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

28 Décembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.050.40453074433712.3612.4112.32119300312.35648572CS
40.050.40453074433712.3612.4112.22105296812.32828296CS
122.1821.309872922810.2312.419.89203167812.11743342CS
264.8764.58885941647.5412.487.22141562411.45816012CS
526.24101.134521886.1712.485.913034649.52924277CS
156-9.17-42.493049119621.5823.2754.070590227711.56194904CS
2605.5580.90379008756.8634.513.0276438213.39604469CS

CDMO - Frequently Asked Questions (FAQ)

What is the current Avid Bioservices share price?
The current share price of Avid Bioservices is US$ 12,41
How many Avid Bioservices shares are in issue?
Avid Bioservices has 63 963 302 shares in issue
What is the market cap of Avid Bioservices?
The market capitalisation of Avid Bioservices is USD 791,87M
What is the 1 year trading range for Avid Bioservices share price?
Avid Bioservices has traded in the range of US$ 5,90 to US$ 12,48 during the past year
What is the PE ratio of Avid Bioservices?
The price to earnings ratio of Avid Bioservices is -5,63
What is the cash to sales ratio of Avid Bioservices?
The cash to sales ratio of Avid Bioservices is 5,66
What is the reporting currency for Avid Bioservices?
Avid Bioservices reports financial results in USD
What is the latest annual turnover for Avid Bioservices?
The latest annual turnover of Avid Bioservices is USD 139,91M
What is the latest annual profit for Avid Bioservices?
The latest annual profit of Avid Bioservices is USD -140,75M
What is the registered address of Avid Bioservices?
The registered address for Avid Bioservices is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Avid Bioservices website address?
The website address for Avid Bioservices is www.peregrineinc.com
Which industry sector does Avid Bioservices operate in?
Avid Bioservices operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
TIRXTian Ruixiang Holdings Ltd
US$ 2,45
(46,71%)
2,25M
RAYRaytech Holding Ltd
US$ 1,63
(20,74%)
366,7k
CJETChijet Motor Company Inc
US$ 2,42
(19,21%)
173,6k
EHGOEshallgo Inc
US$ 3,75
(14,68%)
687
ITRMIterum Therapeutics PLC
US$ 1,88
(13,94%)
34,74k
INTSIntesity Therapeutics Inc
US$ 1,90
(-11,53%)
248
VMARVision Marine Technologies Inc
US$ 1,95
(-9,30%)
941,37k
XTKGX3 Holdings Company Ltd
US$ 1,25
(-8,76%)
4,08k
ARTLArtelo Biosciences Inc
US$ 1,06
(-8,62%)
1k
SYRASyra Health Corporation
US$ 0,55
(-8,32%)
9,37k
GCTKGlucoTrack Inc
US$ 0,1293
(10,51%)
6,12M
CDTConduit Pharmaceuticals Inc
US$ 0,1181
(-4,22%)
4,3M
NVDANVIDIA Corporation
US$ 135,9751
(0,05%)
3,01M
RGTIRigetti Computing Inc
US$ 8,46
(-5,26%)
2,66M
TIRXTian Ruixiang Holdings Ltd
US$ 2,45
(46,71%)
2,25M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
CDMO
Avid Bioservices
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés